Lucid Diagnostics Ownership | Who Owns Lucid Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Lucid Diagnostics Ownership Summary


Lucid Diagnostics is owned by 4.43% institutional investors, 64.95% insiders, and 30.62% retail investors. Luminus management is the largest institutional shareholder, holding 1.61% of LUCD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.74% of its assets in Lucid Diagnostics shares.

LUCD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLucid Diagnostics4.43%64.95%30.62%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryMedical Device Stocks50.53%7.92%41.55%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Luminus management725.83K1.61%$595.18K
Vanguard group560.91K1.25%$459.95K
Geode capital management204.35K0.45%$167.59K
Nantahala capital management126.36K0.28%$103.62K
Lido advisors68.02K0.15%$55.77K
Lpl financial41.46K0.09%$33.99K
Verition fund management39.71K0.09%$32.56K
Geneos wealth management33.85K0.08%$27.76K
Two sigma securities27.75K0.06%$22.76K
Blackrock27.31K0.06%$22.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Luminus management725.83K0.34%$595.18K
Byrne asset management11.00K0.01%$9.56K
Nantahala capital management126.36K0.01%$103.62K
Geneos wealth management33.85K0.00%$27.76K
Virtu financial14.16K0.00%$12.00K
Two sigma securities27.75K0.00%$22.76K
Tower research capital llc (trc)19.80K0.00%$16.23K
Lido advisors68.02K0.00%$55.77K
Verition fund management39.71K0.00%$32.56K
Axiom advisory14.96K0.00%$12.86K

Top Buyers

HolderShares% AssetsChange
Lido advisors68.02K0.00%68.02K
Geode capital management204.35K-48.60K
Two sigma securities27.75K0.00%27.75K
Axiom advisory14.96K0.00%14.96K
Resources investment advisors, llc.13.53K0.00%13.53K

Top Sellers

HolderShares% AssetsChange
Jane street group---122.01K
Hrt financial lp---63.03K
Citadel advisors---29.30K
Blackrock27.31K--24.34K
Nantahala capital management126.36K0.01%-23.34K

New Positions

HolderShares% AssetsChangeValue
Lido advisors68.02K0.00%68.02K$55.77K
Two sigma securities27.75K0.00%27.75K$22.76K
Axiom advisory14.96K0.00%14.96K$12.86K
Resources investment advisors, llc.13.53K0.00%13.53K$11.10K
First manhattan co. llc.12.60K-12.60K$10.33K

Sold Out

HolderChange
Newbridge financial services group-50.00
Citadel advisors-29.30K
Hrt financial lp-63.03K
Jane street group-122.01K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20243214.29%1,993,585-3.75%418.00%15-25.00%950.00%
Mar 31, 20242816.67%2,071,20418.45%428.43%20150.00%6-25.00%
Dec 31, 2023244.35%1,748,600-8.70%419.93%8-27.27%860.00%
Sep 30, 20232343.75%1,915,1592.76%422.12%1183.33%525.00%
Jun 30, 202316-11.11%1,863,7435.39%424.42%6-14.29%433.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv366.92K0.74%-
Vanguard Institutional Extnd Mkt Idx Tr193.99K0.39%-
Fidelity Extended Market Index103.83K0.21%-11.70K
Fidelity Total Market Index56.76K0.12%-
Fidelity Series Total Market Index24.00K0.05%11.76K
Fidelity Nasdaq Composite Index12.87K0.03%-
Spartan Extended Market Index Pool E12.49K0.03%12.49K
Northern Trust Extended Eq Market Idx11.28K0.02%-
NT Ext Equity Mkt Idx Fd - L11.28K0.02%-
BlackRock Extended Equity Market K3.65K0.01%-2.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 25, 2023Lapidus Stanley-Sell$286.00
Sep 26, 2023Lapidus Stanley-Sell$14.30K
Sep 26, 2023Lapidus Stanley-Sell$14.13K
Sep 26, 2023Lapidus Stanley-Sell$14.74K
Sep 20, 2023Lapidus Stanley-Sell$4.94K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q3-10
2023 Q1--
2022 Q4--

LUCD Ownership FAQ


Who Owns Lucid Diagnostics?

Lucid Diagnostics shareholders are primarily institutional investors at 4.43%, followed by 64.95% insiders and 30.62% retail investors. The average institutional ownership in Lucid Diagnostics's industry, Medical Device Stocks, is 50.53%, which Lucid Diagnostics falls below.

Who owns the most shares of Lucid Diagnostics?

Lucid Diagnostics’s largest shareholders are Luminus management (725.82K shares, 1.61%), Vanguard group (560.92K shares, 1.25%), and Geode capital management (204.36K shares, 0.45%). Together, they hold 3.31% of Lucid Diagnostics’s total shares outstanding.

Does Blackrock own Lucid Diagnostics?

Yes, BlackRock owns 0.06% of Lucid Diagnostics, totaling 27.31K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 22.39K$. In the last quarter, BlackRock decreased its holdings by -24.336K shares, a -47.12% change.

Who is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested?

Luminus management is Lucid Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.34% of its assets in 725.82K Lucid Diagnostics shares, valued at 595.18K$.

Who is the top mutual fund holder of Lucid Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lucid Diagnostics shares, with 0.74% of its total shares outstanding invested in 366.92K Lucid Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools